West Pharmaceutical Services Investments decreased by 1.5% to $209.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from $211.90M to $209.20M. Over 5 years (FY 2020 to FY 2025), Investments shows relatively stable performance with a -0.2% CAGR.
An increase suggests strategic expansion or partnership growth, while a decrease may indicate divestment or impairment of these interests.
These are long-term investments in other entities, such as joint ventures, associates, or subsidiaries, where the compan...
Common for large industrial firms that utilize joint ventures for global infrastructure projects.
non_current_assets_investments_in_affiliates_subsidiarie_2849e6| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $211.70M | $215.70M | $207.70M | $208.10M | $193.30M | $188.60M | $204.90M | $208.80M | $202.80M | $195.40M | $210.00M | $202.50M | $198.20M | $217.50M | $202.10M | $211.90M | $224.70M | $220.90M | $212.30M | $209.20M |
| QoQ Change | — | +1.9% | -3.7% | +0.2% | -7.1% | -2.4% | +8.6% | +1.9% | -2.9% | -3.6% | +7.5% | -3.6% | -2.1% | +9.7% | -7.1% | +4.8% | +6.0% | -1.7% | -3.9% | -1.5% |
| YoY Change | — | — | — | — | -8.7% | -12.6% | -1.3% | +0.3% | +4.9% | +3.6% | +2.5% | -3.0% | -2.3% | +11.3% | -3.8% | +4.6% | +13.4% | +1.6% | +5.0% | -1.3% |